IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 289 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $4,669,184 | +248.7% | 105,566 | +139.9% | 0.04% | +387.5% |
Q4 2021 | $1,338,920 | -9.6% | 44,000 | -0.3% | 0.01% | -27.3% |
Q3 2021 | $1,480,355 | -70.5% | 44,137 | -64.9% | 0.01% | -65.6% |
Q2 2021 | $5,014,333 | -48.6% | 125,704 | -42.1% | 0.03% | -62.8% |
Q1 2021 | $9,762,030 | +764.3% | 217,127 | +986.9% | 0.09% | +855.6% |
Q4 2020 | $1,129,443 | +127.3% | 19,976 | +142.9% | 0.01% | +125.0% |
Q4 2019 | $497,000 | -72.8% | 8,223 | -73.0% | 0.00% | -71.4% |
Q3 2019 | $1,827,000 | +60.1% | 30,492 | +71.8% | 0.01% | +75.0% |
Q2 2019 | $1,141,000 | -64.8% | 17,748 | -55.6% | 0.01% | -69.2% |
Q1 2019 | $3,246,000 | +263.1% | 40,000 | +141.8% | 0.03% | +271.4% |
Q4 2018 | $894,000 | +323.7% | 16,542 | +303.5% | 0.01% | +600.0% |
Q3 2018 | $211,000 | -88.4% | 4,100 | -90.6% | 0.00% | -90.9% |
Q2 2018 | $1,815,000 | +195.6% | 43,559 | +259.5% | 0.01% | +175.0% |
Q3 2017 | $614,000 | +5.7% | 12,116 | +6.1% | 0.00% | 0.0% |
Q2 2017 | $581,000 | -49.8% | 11,415 | -60.4% | 0.00% | -55.6% |
Q1 2017 | $1,158,000 | -84.8% | 28,816 | -81.9% | 0.01% | -79.1% |
Q4 2016 | $7,625,000 | -9.9% | 159,400 | -31.0% | 0.04% | -4.4% |
Q3 2016 | $8,464,000 | +2218.9% | 231,012 | +1375.5% | 0.04% | +2150.0% |
Q2 2016 | $365,000 | -47.3% | 15,656 | -8.4% | 0.00% | -50.0% |
Q1 2016 | $693,000 | -84.6% | 17,100 | -76.5% | 0.00% | -84.0% |
Q4 2015 | $4,505,000 | – | 72,747 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |